Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Colin

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
The American Review of Respiratory Disease|July 1, 1993
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisB W Ramsey, S J Astley, M L Aitken, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2001
Forced expiratory flow in uninfected infants and children born to HIV-infected mothersA A Colin, J Sunil Rao, X C Chen, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbationsR W Wilmott, R S Amin, A A Colin, et al.
Pediatric Pulmonology|September 25, 1999
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and CanadaW J Morgan, S M Butler, C A Johnson, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
The American Review of Respiratory Disease|July 1, 1993
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisB W Ramsey, S J Astley, M L Aitken, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2001
Forced expiratory flow in uninfected infants and children born to HIV-infected mothersA A Colin, J Sunil Rao, X C Chen, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbationsR W Wilmott, R S Amin, A A Colin, et al.
Pediatric Pulmonology|September 25, 1999
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and CanadaW J Morgan, S M Butler, C A Johnson, et al.
Pageof 5